By Vikas S. Dhar, Managing Partner, Dhar Law LLP

When Matthew Perry — one of the most beloved television actors of a generation — was found face down in his Pacific Palisades hot tub on October 28, 2023, the cause of death was ultimately listed as the acute effects of ketamine. But behind the headlines, another story unfolded in federal court. It was a story that every person facing a drug-related charge, and every family touched by the criminal justice system, should understand.

The criminal case that followed Perry’s death was not an outlier. As a federal criminal defense attorney with over 23 years of experience handling some of the most complex narcotics and drug trafficking cases in Massachusetts and the First Circuit, my role is to cut through the noise and explain how the lessons of this case can be applied legally, personally, and tactically if you or someone you love is facing federal drug charges.

THE PERRY CASE: WHAT ACTUALLY HAPPENED

Federal prosecutors in the Central District of California charged five individuals in connection with Perry’s death. These included Jasveen Sangha, a North Hollywood-based dealer dubbed the “Ketamine Queen” who prosecutors allege ran a high-volume drug trafficking operation catering to A-list clientele. After all five defendants entered guilty pleas, Sangha appeared before a federal judge on April 8, 2026 for sentencing. The government is seeking 15 years in federal prison while her attorneys are asking for time served.

What makes this a landmark case is the explicit message delivered by then-U.S. Attorney E. Martin Estrada at the time of indictment warning that dealers are “on full notice” that the products they sell could result in the death of another person. This is not rhetoric. It is a prosecutorial roadmap that indicates an aggressive nationwide shift in the way that federal drug cases are charged, investigated, and sentenced.

Perry’s case also uncovered a second tragic thread: the 2019 overdose death of aspiring personal trainer Cody McLaury. Prosecutors allege McLaury was also connected to Sangha. 

A NEW ERA OF FEDERAL DRUG ACCOUNTABILITY

The Perry prosecution sits at the intersection of several converging trends that have fundamentally reshaped the federal drug enforcement landscape. Whether your case involves ketamine, fentanyl, cocaine, heroin, or prescription narcotics, many of the following dynamics are now in play across every major U.S. district:

• Overdose death charges as a federal weapon. Federal prosecutors are increasingly using 21 U.S.C. § 841(b)(1)(C)’s “death results” enhancement, carrying a mandatory minimum sentence of 20 years, against suppliers, mid-level dealers, and distributors whose product is traceable to a fatality. This provision is no longer reserved for cartel lieutenants.

• High-profile cases drive policy. The Perry prosecution, like the Mac Miller and Tyler Skaggs cases before it, creates institutional pressure on U.S. Attorneys’ offices to demonstrate seriousness. Prosecutors use high-visibility cases to signal a culture of accountability. That culture filters down to every case on their docket.

• Digital evidence is devastating. Sangha’s clients allegedly paid via Venmo. Text messages formed a key evidentiary thread. In today’s federal drug investigations, electronic communications, payment platforms, and social media are treated as crime scenes. The trail is rarely as untraceable as defendants believe.

• Sentencing enhancements stack quickly. From drug quantity to leadership role, prior criminal history to use of a minor, federal sentencing guidelines create a framework where a seemingly mid-level participant can face decades in prison. Without a skilled advocate at sentencing, the guidelines can overwhelm even sympathetic facts.

• International supply chains draw international attention. In cases involving narcotics sourced from Colombia, Mexico, or the Dominican Republic, federal investigations routinely involve DEA, Homeland Security Investigations, and requests for international extradition. A domestic arrest is often only the beginning of a much larger case.

WHAT THIS MEANS IF YOU ARE FACING FEDERAL DRUG CHARGES

Federal drug cases are not like state cases. The resources, the investigative depth, and the sentencing exposure are categorically different. If federal agents or prosecutors are involved — even in an ancillary way — you need federal criminal defense counsel, not a general legal practitioner.

During my time at Dhar Law LLP, I have spent more than two decades navigating every dimension of federal narcotics defense: from pre-indictment negotiations and grand jury strategy to suppression motions, trial, and sentencing advocacy before federal judges across the First Circuit. I have litigated these issues in the District of Massachusetts, the District of New Hampshire, and in international proceedings where extradition is at stake — for example in cases originating in Colombia, Mexico, and the Dominican Republic.

What effective defense in these cases actually looks like:

• Challenging the investigation at its roots. Whether the government relied on a confidential informant, a wiretap, GPS tracking, or digital surveillance, every federal drug investigation has legal vulnerabilities. Motions to suppress evidence — when properly researched and argued — can gut the government’s case before trial even begins.

• Contesting drug quantity. Sentencing in federal drug cases is largely driven by drug weight. What the government claims is attributable to you and what can actually be proved beyond a reasonable doubt are frequently very different things. Quantity challenges, properly litigated, can mean the difference between years and decades of incarceration.

• Humanizing the client. Federal sentencing is not mechanical — judges have discretion, and they exercise it. A comprehensive, narrative-driven sentencing memorandum, supported by character evidence, forensic evaluation, and documented mitigation, is one of the most powerful tools a defense attorney can deploy. I have obtained results well below advisory guidelines in cases that appeared, on paper, to be straightforward.

• Extradition defense. If you or a family member is the subject of a U.S. extradition request from Colombia, Mexico, or the Dominican Republic — or if a foreign government has issued an Interpol Red Notice — the time to act is immediately. I have handled international extradition matters involving narcotics trafficking with a depth of experience that few attorneys in New England can match.

• Cooperation strategy. Not every federal drug case should go to trial. When cooperation is in a client’s genuine interest, early, strategic proffer sessions handled by experienced counsel can meaningfully shape outcomes. When cooperation is not in a client’s interest, having counsel who understands why matters just as much.

THE STAKES ARE TOO HIGH TO WAIT

The Matthew Perry case, and the criminal reckoning it triggered, is a reminder that federal drug prosecutions are serious, sophisticated, and relentless. The government had every advantage in this case: surveillance, digital records, cooperating witnesses — and the full weight of a high-profile public narrative. And yet, effective defense counsel still shaped outcomes, still negotiated pleas, and still stood at sentencing to argue for more leniency than what prosecutors demanded.

If you or a loved one is under federal investigation for a drug offense, has been charged with a narcotics crime in federal court, or is facing extradition proceedings related to drug trafficking allegations from Colombia, Mexico, or the Dominican Republic, do not wait. The decisions made in the earliest hours and days of a federal case often determine its ultimate trajectory. Contact a member of our team at 617-880-6155 to find out how we can put our experience and commitment to work for you.